Outcome of adjuvant imatinib in patients with gastrointestinal stromal tumor: Results of a population-based, matched cohort study. Influence of imatinib interruption and imatinib rechallenge on the ...

Duodenal gastrointestinal stromal tumors (DGISTs) represent a rare subset of mesenchymal neoplasms of the gastrointestinal tract, accounting for approximately 3–5% of all gastrointestinal stromal ...

GISTs are solid tumors, primarily in the stomach, characterized by KIT and EGFR mutations, with Gleevec as a key treatment.

GISTs originate from interstitial cells of Cajal and are staged by size, location, mitotic rate, and genetic mutations, influencing treatment strategies. Diagnosis involves imaging, endoscopy, biopsy, ...

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative ...

A new technique in which near-infrared hyperspectral imaging (NIR-HSI) is combined with machine learning could be useful for detecting cancers deep within tissue, suggests a research team from Japan.

Researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer. Because ...

If you have advanced gastrointestinal stromal tumor (GIST), you may not know anyone else with the disease. This may leave you with a lot of questions about what life will be like with this rare cancer ...

Association of the genetic variants in the nucleotide excision repair genes XPA and XPC with cisplatin-induced hearing loss in patients with osteosarcoma. Relationship of CUL4A gene underexpression ...